Advertisement

Topics

Janssen’s Apalutamide First To Gain Approval Under International Work Sharing Program

07:41 EDT 9 Jul 2018 | SCRIP

The ACSS Consortium’s work-sharing pilot for new drugs has yielded its first twin approval, for Janssen’s prostate cancer treatment, apalutamide.

      

Related Stories

 

Original Article: Janssen’s Apalutamide First To Gain Approval Under International Work Sharing Program

NEXT ARTICLE

More From BioPortfolio on "Janssen’s Apalutamide First To Gain Approval Under International Work Sharing Program"

Advertisement
Quick Search
Advertisement
Advertisement